These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38372755)

  • 1. Neuroprotective effects of levothyroxine on cognition deficits and memory in an experimental model of Huntington's disease in rats: An electrophysiological study.
    Badini F; Mirshekar MA; Shahraki S; Fanaei H; Bayrami A
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Aug; 397(8):5939-5951. PubMed ID: 38372755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levothyroxine attenuates behavioral impairment and improves oxidative stress and histological alteration 3-nitropropionic acid induced experimental Huntington's disease in rats.
    Badini F; Bayrami A; Mirshekar MA; Shahraki S; Fanaei H
    Behav Brain Res; 2024 Mar; 461():114864. PubMed ID: 38220060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats.
    Danduga RCSR; Dondapati SR; Kola PK; Grace L; Tadigiri RVB; Kanakaraju VK
    Biomed Pharmacother; 2018 Sep; 105():1254-1268. PubMed ID: 30021362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of levothyroxine on learning and memory deficits in a rat model of Alzheimer's disease: the role of BDNF and oxidative stress.
    Bavarsad K; Hadjzadeh MA; Hosseini M; Pakdel R; Beheshti F; Bafadam S; Ashaari Z
    Drug Chem Toxicol; 2020 Jan; 43(1):57-63. PubMed ID: 29927658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agmatine mitigates behavioral abnormalities and neurochemical dysregulation associated with 3-Nitropropionic acid-induced Huntington's disease in rats.
    Katariya R; Mishra K; Sammeta S; Umekar M; Kotagale N; Taksande B
    Neurotoxicology; 2024 May; 102():12-28. PubMed ID: 38453033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease.
    Kumar P; Kumar A
    J Med Food; 2009 Jun; 12(3):591-600. PubMed ID: 19627208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-theanine, a Component of Green Tea Prevents 3-Nitropropionic Acid (3-NP)-Induced Striatal Toxicity by Modulating Nitric Oxide Pathway.
    Jamwal S; Kumar P
    Mol Neurobiol; 2017 Apr; 54(3):2327-2337. PubMed ID: 26957301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effect of solanesol against 3-nitropropionic acid-induced Huntington's disease-like behavioral, biochemical, and cellular alterations: Restoration of coenzyme-Q10-mediated mitochondrial dysfunction.
    Mehan S; Monga V; Rani M; Dudi R; Ghimire K
    Indian J Pharmacol; 2018; 50(6):309-319. PubMed ID: 30783323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of an Angiotensin IV Analog on 3-Nitropropionic Acid-Induced Huntington's Disease-Like Symptoms in Rats.
    Wells RG; Azzam AF; Hiller AL; Sardinia MF
    J Huntingtons Dis; 2024; 13(1):55-66. PubMed ID: 38489193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of safranal or candesartan on 3-nitropropionicacid-induced biochemical, behavioral and histological alterations in a rat model of Huntington's disease.
    Shehata NI; Abd El-Salam DM; Hussein RM; Rizk SM
    PLoS One; 2023; 18(11):e0293660. PubMed ID: 37910529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ameliorating effect of Celastrus paniculatus standardized extract and its fractions on 3-nitropropionic acid induced neuronal damage in rats: possible antioxidant mechanism.
    Malik J; Karan M; Dogra R
    Pharm Biol; 2017 Dec; 55(1):980-990. PubMed ID: 28164735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vildagliptin Attenuates Huntington's Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model.
    Sayed NH; Fathy N; Kortam MA; Rabie MA; Mohamed AF; Kamel AS
    Neurotherapeutics; 2020 Jan; 17(1):252-268. PubMed ID: 31728850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington's disease in rats.
    Tariq M; Khan HA; Elfaki I; Al Deeb S; Al Moutaery K
    Brain Res Bull; 2005 Sep; 67(1-2):161-8. PubMed ID: 16140176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of LOX/COX pathways in 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats: protective effect of licofelone.
    Kumar P; Kalonia H; Kumar A
    Br J Pharmacol; 2011 Sep; 164(2b):644-54. PubMed ID: 21486276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial modulators improve lipid composition and attenuate memory deficits in experimental model of Huntington's disease.
    Mehrotra A; Sood A; Sandhir R
    Mol Cell Biochem; 2015 Dec; 410(1-2):281-92. PubMed ID: 26374445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective activity of L-theanine on 3-nitropropionic acid-induced neurotoxicity in rat striatum.
    Thangarajan S; Deivasigamani A; Natarajan SS; Krishnan P; Mohanan SK
    Int J Neurosci; 2014 Sep; 124(9):673-84. PubMed ID: 24325390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ellagic acid prevents 3-nitropropionic acid induced symptoms of Huntington's disease.
    Sharma P; Kumar M; Bansal N
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Sep; 394(9):1917-1928. PubMed ID: 34061228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington's disease model in rats.
    Suganya SN; Sumathi T
    Metab Brain Dis; 2017 Apr; 32(2):471-481. PubMed ID: 27928694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial cofactors in experimental Huntington's disease: behavioral, biochemical and histological evaluation.
    Mehrotra A; Sandhir R
    Behav Brain Res; 2014 Mar; 261():345-55. PubMed ID: 24393741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel therapeutic application of solid lipid nanoparticles encapsulated thymoquinone (TQ-SLNs) on 3-nitroproponic acid induced Huntington's disease-like symptoms in wistar rats.
    Ramachandran S; Thangarajan S
    Chem Biol Interact; 2016 Aug; 256():25-36. PubMed ID: 27206696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.